Literature DB >> 6439764

Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients.

Y Poulin, H O Perry, S A Muller.   

Abstract

Between 1974 and 1981, thirteen patients with pemphigus vulgaris were treated with prednisone supplemented by gold salts. Therapy resulted in excellent responses in eleven of the thirteen, with complete remission in seven. At a mean follow-up of 48.8 months, five patients still had complete remission and required no further treatment. Treatment of pemphigus vulgaris initially with prednisone followed by gold compounds is recommended as an important modality with relatively low morbidity and may permit lower effective doses of corticosteroids to be employed, occasionally even permitting their complete withdrawal.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439764     DOI: 10.1016/s0190-9622(84)80463-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  RECENT TRENDS IN THE MANAGEMENT OF PEMPHIGUS VULGARIS.

Authors:  P K Kar
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Therapy of autoimmune bullous diseases.

Authors:  Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

Review 3.  A review on botanicals with wound healing activity for pemphigus vulgaris: perspective of traditional Persian medicine and conventional medicine.

Authors:  Fatemeh Atarzadeh; Amir Mohammad Jaladat; Babak Daneshfard; Ladan Dastgheib; Mohammad Kamalinejad; Gholamreza Amin
Journal:  Avicenna J Phytomed       Date:  2017 Nov-Dec

Review 4.  Cassia fistula: A remedy from Traditional Persian Medicine for treatment of cutaneous lesions of pemphigus vulgaris.

Authors:  Fatemeh Atarzadeh; Mohammad Kamalinejad; Ladan Dastgheib; Gholamreza Amin; Amir Mohammad Jaladat; Majid Nimrouzi
Journal:  Avicenna J Phytomed       Date:  2017 Mar-Apr

5.  Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes.

Authors:  Deepak N Subramanian; Magnus Zethoven; Simone McInerny; James A Morgan; Simone M Rowley; Jue Er Amanda Lee; Na Li; Kylie L Gorringe; Paul A James; Ian G Campbell
Journal:  Nat Commun       Date:  2020-04-02       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.